David Cohen, MD, PhD

Highlights

1
Cell metabolism · 2020
TKTibor Krisko KYKyu Y. Rhee DCDavid Cohen
PMID: 32084379PMCID: PMC7888548DOISenior author67 citations

Publications

175

Funding

17 View NIH portfolio on RePORTER ↗

Active

3 grants

MPI
Them1 Inhibitors for the Management of Non Alcoholic Fatty Liver Disease
NIDDK · 2023–2028 · via NIH RePORTER
R01DK133988-04
PI
Research Training in Gastrointestinal and Hepatic Diseases
NIDDK · 2023–2028 · via NIH RePORTER
T32DK135449-02
PI
Lipid Mediated Control Transfer of Acetyl CoA Metabolism in the Pathogenesis of NAFLD
NIDDK · 1996–2027 · via NIH RePORTER
R01DK048873-31

Completed grants (14)

MPI
Multidisciplinary Research Training in Gastroenterology and Hepatology
National Institute of Diabetes and Digestive and Kidney Diseases · 2019–2025Training
T32DK116970-03
Co-I
The role of PKM2 in dietary lipid absorption and fructose-induced obesity
National Institute of Diabetes and Digestive and Kidney Diseases · 2022–2024
R01DK132427-01
PI
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD
National Institute of Diabetes and Digestive and Kidney Diseases · 2017–2023· 2 renewals
R01DK103046-09
PI
Them1 Inhibitors for the Management of Obesity-Related Disorders
Daedalus Fund for Innovation (Weill Cornell) · 2021–2022BioPharma Alliance
DFI 221754-01
PI
Leveraging Gut Microbial Adaption to Thermal and Nutritional-Stress in the Management of Obesity-Related Metabolic Disorders and Vascular Aging
Kaohsiung Medical University · 2019–2022Contract
SRA 200523-01
PI
Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2
National Institute of Diabetes and Digestive and Kidney Diseases · 2017–2022· 2 renewals
R37DK048873-27
PI
Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLD
National Institute of Diabetes and Digestive and Kidney Diseases · 2017–2022· 2 renewals
R01DK056626-23
KP
Acot9 Promotes Lipotoxicity
National Institute of Diabetes and Digestive and Kidney Diseases · 2019–2021
R03DK117247-01A1
KP
Muscle-specific metabolic regulation by thioesterase superfamily member 2 (Them2)
American Heart Association · 2019–2020
AHA 19POST34380692
PI
Sanofi Innovation Awards Program Funding Award Agreement
Sanofi S.A. · 2017–2020Contract
SUS 182871-01
PI
Them1 Inhibitors for the Management of Obesity-Related Disorders
Daedalus Fund for Innovation (Weill Cornell) · 2017–2018
DFI 180060-01
Sub-PI
IRE1a and XBP1 Dependent MicroRNAs and Their Role in Hepatic Lipid Metabolism
Qatar National Research Fund · 2015–2018 · via Weill Cornell Medical College/Qatar
NPRP 7-1300-1-241
PI
MOLECULAR AND CELLULAR BIOCHEMISTRY CORE
NIDDK · 1997–2015 · via NIH RePORTER
P30DK034854-30
PI
Etiology of Cystic Fibrosis-Related Diabetes in a CFTR-knockout Ferret
NIDDK · 2011–2013 · via NIH RePORTER
R24DK091211-01

Honors & distinctions

Member · Association of American Physicians · 2020
Member · American Society for Clinical Investigation · 2003

News mentions

1 View all WCM news ↗

Gut Microbiome Controls Blood Glucose Levels Through the Liver
February 20, 2020
Gut microbes influence blood glucose levels by acting directly on the liver, not by regulating the energy expenditure of specialized fat tissues, which use glucose as fuel to create heat.

External relationships

Other Interest

Aegerion Pharmaceuticals · American Association for the Study of Liver Diseases Foundation · Beijing Association of Precision Medicine · Esperion Therapeutics · Intercept Pharmaceuticals, INC · PTC Therapeutics · Relburn-Metabolomics, Inc. · Surrozen, Inc.